6 Committee comments
6.1 The Committee noted that there are different types of bioresorbable stents, which may vary in safety and efficacy. It also noted that the technology for this procedure continues to evolve.
6.2 The Committee noted that majority of the evidence is from drug-eluting bioresorbable stents.
6.3 The Committee noted that there are several ongoing trials on bioresorbable stent implantation for treating coronary artery disease.